Potensial Of Astragalus As Adjuvant Therapy In Glomerulonephritis Patient
DOI:
https://doi.org/10.53089/medula.v13i5.783Keywords:
Astragalus membranaceus, glomerulonephritis, therapyAbstract
Glomerulonephritis is a medical term used to describe a condition that involves some kidney damages. Glomerulonephritis is an abnormality of the kidney that may lead to end-stage renal disease (ESRD). The current glomerulonephritis therapy is considered not fully effective due to the possibility of additional morbidity and complications that may occur. The use of Astragalus as adjuvant therapy can inhibit the progression of glomerulonephritis. The journals, that was reviewed, obtained from the Google Scholar, Sciencedirect, PubMed, and Springer with a publication year range of 2009-2023. The journals were selected to obtain valid and reliable journals, then do a literature review and article writing. Astragalus membranaceus has a bioactive content that can act as an immunomodulator, antiinflamation, and renoprotector. Astragalus is able to improve kidney function through IL-6 secretion and improve kidney interstitial fibrosis. Administration of Astragalus in combination with conventional therapy can reduce serum creatinine and proteinuria. Astragalus has potential as adjuvant therapy in glomerulonephritis patients.
References
Kazi, A. M., Hashmi, M. F. Glomerulonephritis. Treasure Island (FL): StatPearls Publishing; 2022 [diperbarui tanggal 19 Februari 2022; disitasi tanggal 30 Mei 2023]. Tersedia dari: https://www.ncbi.nlm.nih.gov/books/NBK560644/
Halfon M, Pruijm M. Glomérulonéphrites. Swiss Med Forum. 2017;17(13):298–305.
Nanchen, G., Schutzbach, K., Rotman, S., Winzeler, R., Ambühl, P., Halfon, M., & Pruijm, M. Incidence of glomerulonephritis in the western part of Switzerland over the last decade. Swiss medical weekly. 2020;150:20353.
McGrogan A, Franssen CF, de Vries CS. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant. 2011;26(2):414–30.
Zhang, H. W., Lin, Z. X., Xu, C., Leung, C., & Chan, L. S. Astragalus (a traditional Chinese medicine) for treating chronic kidney disease. The Cochrane database of systematic reviews. 2014; (10): 8369.
Farag, M., & Alagawany, M. The role of Astragalus membranaceus as immunomodulator in poultry. World's Poultry Science Journal. 2019;75(1):43-54.
Zhao, L. H., Ma, Z. X., Zhu, J., Yu, X. H., Weng, D. P. Characterization of polysaccharide from Astragalu radix as the macrophage stimulator. Cell Immunol. 2011;271(2): 329-334.
Li, B. and Zhang, Y. Physiological function and application in prologue production of Astragalus. Animal Breeding and Feed. 2009;1: 4344.
Nowack, R., Flores-Suárez, F., Birck, R., Schmitt, W., & Benck, U. Herbal treatments of glomerulonephritis and chronic renal failure: Review and recommendations for research. Academia Journals. 2011; 3(9):124-136.
Selvaskandan, H., Cheung, C. K., Muto, M., & Barratt, J. New strategies and perspectives on managing IgA nephropathy. Clinical and experimental nephrology. 2019;23(5): 577–588.
Ji, L., Chen, X., Zhong, X., Li, Z., Yang, L., Fan, J., Tang, W., & Qin, W. Astragalus membranaceus up-regulate Cosmc expression and reverse IgA dys-glycosylation in IgA nephropathy. BMC complementary and alternative medicine. 2014;14: 195.
Jiangbo Z, Xuying W, Yuping Z, Xili M, Yiwen Z, Tianbao Z. Effect of astragaloside IV on the embryo-fetal development of Sprague-Dawley rats and New Zealand White rabbits. J. Appl. Toxicol. 2009.;29(5): 381-385.
Li, S.P., Zhao, X.J. and Wang, J.Y. Synergy of Astragalus polysaccharides and probiotics (Lactobacillus and Bacillus cereus) on immunity and intestinal microbiota in chicks. Poultry Science. 2009;88: 519-525.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
